Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2021-09-24 20:15:53 UTC |
---|
Update Date | 2021-09-24 20:15:53 UTC |
---|
HMDB ID | HMDB0304863 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Pemigatinib |
---|
Description | Pemigatinib, also known as pemazyre, belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond. Based on a literature review a significant number of articles have been published on Pemigatinib. |
---|
Structure | CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F InChI=1S/C24H27F2N5O4/c1-4-30-21-14(11-27-23-16(21)9-15(28-23)13-29-5-7-35-8-6-29)12-31(24(30)32)22-19(25)17(33-2)10-18(34-3)20(22)26/h9-11H,4-8,12-13H2,1-3H3,(H,27,28) |
---|
Synonyms | |
---|
Chemical Formula | C24H27F2N5O4 |
---|
Average Molecular Weight | 487.508 |
---|
Monoisotopic Molecular Weight | 487.203110695 |
---|
IUPAC Name | 11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-ethyl-4-[(morpholin-4-yl)methyl]-5,7,11,13-tetraazatricyclo[7.4.0.0^{2,6}]trideca-1,3,6,8-tetraen-12-one |
---|
Traditional Name | 11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-ethyl-4-(morpholin-4-ylmethyl)-5,7,11,13-tetraazatricyclo[7.4.0.0^{2,6}]trideca-1,3,6,8-tetraen-12-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F |
---|
InChI Identifier | InChI=1S/C24H27F2N5O4/c1-4-30-21-14(11-27-23-16(21)9-15(28-23)13-29-5-7-35-8-6-29)12-31(24(30)32)22-19(25)17(33-2)10-18(34-3)20(22)26/h9-11H,4-8,12-13H2,1-3H3,(H,27,28) |
---|
InChI Key | HCDMJFOHIXMBOV-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Biphenyls and derivatives |
---|
Direct Parent | Biphenyls and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Biphenyl
- Aminobenzamide
- Aminobenzoic acid or derivatives
- Benzamide
- Toluamide
- O-toluamide
- Benzoic acid or derivatives
- Benzoyl
- Benzylamine
- Tertiary aliphatic/aromatic amine
- Aminotoluene
- Aniline or substituted anilines
- Dialkylarylamine
- Phenylmethylamine
- Dihydropyridine
- Aralkylamine
- Methylpyridine
- Toluene
- Pyridinone
- Hydropyridine
- Morpholine
- Oxane
- Oxazinane
- Pyridine
- Heteroaromatic compound
- Tertiary amine
- Secondary carboxylic acid amide
- Tertiary aliphatic amine
- Amino acid or derivatives
- Lactam
- Carboxamide group
- Organoheterocyclic compound
- Oxacycle
- Carboxylic acid derivative
- Dialkyl ether
- Azacycle
- Ether
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Amine
- Organooxygen compound
- Organic oxygen compound
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Pemigatinib,1TMS,isomer #1 | CCN1C(=O)N(C2=C(F)C(OC)=CC(OC)=C2F)CC2=CN=C3C(=C21)C=C(CN1CCOCC1)N3[Si](C)(C)C | 3757.7 | Semi standard non polar | 33892256 | Pemigatinib,1TMS,isomer #1 | CCN1C(=O)N(C2=C(F)C(OC)=CC(OC)=C2F)CC2=CN=C3C(=C21)C=C(CN1CCOCC1)N3[Si](C)(C)C | 3526.3 | Standard non polar | 33892256 | Pemigatinib,1TMS,isomer #1 | CCN1C(=O)N(C2=C(F)C(OC)=CC(OC)=C2F)CC2=CN=C3C(=C21)C=C(CN1CCOCC1)N3[Si](C)(C)C | 5010.6 | Standard polar | 33892256 | Pemigatinib,1TBDMS,isomer #1 | CCN1C(=O)N(C2=C(F)C(OC)=CC(OC)=C2F)CC2=CN=C3C(=C21)C=C(CN1CCOCC1)N3[Si](C)(C)C(C)(C)C | 3855.7 | Semi standard non polar | 33892256 | Pemigatinib,1TBDMS,isomer #1 | CCN1C(=O)N(C2=C(F)C(OC)=CC(OC)=C2F)CC2=CN=C3C(=C21)C=C(CN1CCOCC1)N3[Si](C)(C)C(C)(C)C | 3726.0 | Standard non polar | 33892256 | Pemigatinib,1TBDMS,isomer #1 | CCN1C(=O)N(C2=C(F)C(OC)=CC(OC)=C2F)CC2=CN=C3C(=C21)C=C(CN1CCOCC1)N3[Si](C)(C)C(C)(C)C | 4996.7 | Standard polar | 33892256 |
|
---|